流動資産 変化する 日付
Acadia Pharmaceuticals USD 1.27B 43.88M 2026-09
Agios Pharmaceuticals USD 752.1M 34.43M 2026-09
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amarin USD 612.88M 10.12M 2026-09
Amgen USD 34.36B 598M 2026-09
Baxter International USD 6.83B 163M 2026-09
Cara Therapeutics USD 23.13M 2.2M 2026-09
Cytokinetics USD 1.19B 21.34M 2026-09
DBV Technologies USD 189.6M 12.3M 2026-09
Eli Lilly USD 65.26B 591M 2026-09
Halozyme Therapeutics USD 1.85B 913.71M 2026-09
Intrexon USD 23.72M 45.04M 2024-06
Ionis Pharmaceuticals USD 2.36B 129.77M 2026-09
MannKind USD 240.48M 5.24M 2026-09
Minerva Neurosciences USD 83.1M 70.08M 2025-12
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Pfizer USD 45.01B 3.65B 2026-09
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
United Therapeutics USD 2.88B 603.5M 2026-09
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12